This task order is for determination of the in vitro inhibitory effect of experimental antibacterial substances in determinations against bacterial pathogens, including the bacterial species…
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
The University Of Texas Health Science Center At San Antonio UEI C3KXNLTAAY98 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $126,264
Award facts
- Contract value 100% obligated
- $126,264.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Antonio, TX 78229, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $21,044 | |
| Other Administrative Action | $0 | |
| Original award | $105,220 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,264 firm fixed price delivery order to the University of Texas Health Science Center of San Antonio under the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity multiple award contract vehicle. This task order is for the determination of the in vitro inhibitory effect of experimental antibacterial substances against the bacterial pathogens identified in Table 1 using MIC and MIC 90 assays. Performance will take place in San Antonio, Texas, over a one year period from July 2021 through July 2022. No socioeconomic designations or subcontractors were identified. The work furthers NIAID's mission to conduct and support research on infectious and immune-mediated diseases.
Description
This task order is for determination of the in vitro inhibitory effect of experimental antibacterial substances in determinations against bacterial pathogens, including the bacterial species identified in table 1 below, using MIC and MIC 90.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to The University Of Texas Health Science Center At San Antonio by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 27, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $126,264 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93019D00022, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award